Indications
Treatment of acute heart failure
Composition
- Active substance
- serelaxin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Reasanz
- Active substance
- serelaxin
- ATC code
- C01DX21
- Therapeutic area
- Heart Failure
- Marketing authorisation holder
- Novartis Europharm Ltd
- Status
- Refused
- Refused
- 5 Aug 2014
- EMA product number
- EMEA/H/C/002817